4.6 Article

Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics

Journal

GENETICS IN MEDICINE
Volume 22, Issue 7, Pages 1235-1246

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1038/s41436-020-0787-4

Keywords

ABCA4; Stargardt disease; smMIPs; deep-intronic variants; structural variants

Funding

  1. RetinaUK [GR591]
  2. Fighting Blindness Ireland grant [FB18CRE]
  3. Horizon 2020, Marie SklodowskaCurie Innovative Training Network
  4. Frequent Inherited Blinding Disorder-StarT [813490]
  5. Foundation Fighting Blindness USA [PPA-0517-0717-RAD]
  6. Rotterdamse Stichting Blindenbelangen
  7. Stichting Blindenhulp
  8. Landelijke Stichting voor Blinden en Slechtzienden
  9. Macula Degeneratie fonds
  10. Stichting Blinden-Penning
  11. Algemene Nederlandse Vereniging ter Voorkoming van Blindheid
  12. Stichting tot Verbetering van het Lot der Blinden
  13. Groupement de Cooperation Sanitaire Interregional G4 qui reunit les Centres Hospitaliers Universitaires Amiens, Caen, Lille et Rouen (GCS G4)
  14. Fondation Stargardt France
  15. Federal Ministry of Education and Research (BMBF) [01GM0851, 01GM1108B]
  16. Charles University [SVV 260516, UNCE 204064, PROGRES-Q26/LF1]
  17. Fighting Blindness Ireland
  18. Health Research Board of Ireland
  19. Medical Research Charities Group [MRCG-201614]
  20. Ghent University Research Fund [BOF15/GOA/011]
  21. Research Foundation Flanders (FVO) [G0C6715N]
  22. Hercules foundation [AUGE/13/023]
  23. JED Foundation
  24. FWO
  25. funds for Research in Ophthalmology (FRO)
  26. FWO [1802215N, 1802220N]
  27. Conchita Rabago Foundation
  28. Boehringer Ingelheim Fonds
  29. ISCIII - European Regional Development Fund (ERDF) [PI16/0425]
  30. RAREGenomics-CM (CAM) [B2017/BMD-3721]
  31. ONCE
  32. Ramon Areces Foundation
  33. Peace for Sight grant
  34. Retina South Africa
  35. South African Medical Research Council (MRC)
  36. Foundation Fighting Blindness [BR-GE-0214-0639-TECH, BR-GE-0518-0734TECH]
  37. Israeli Ministry of Health [3-12583Q4]
  38. Olive Young Fund, University Hospital Foundation, Edmonton
  39. National Science Center (Poland) [N N402 591640, 5916/B/P01/2011/40, UMO-2015/19/D/NZ2/03193]
  40. Italian Fondazione Roma
  41. Italian Telethon Foundation
  42. Ministero dell'Istruzione del l'Universita e della Ricerca (MIUR) under PRIN 2015
  43. Daljit S. and Elaine Sarkaria Charitable Foundation
  44. [AZV NU20-07-00182]
  45. [AZV NU20-0700182]

Ask authors/readers for more resources

Purpose Missing heritability in human diseases represents a major challenge, and this is particularly true for ABCA4-associated Stargardt disease (STGD1). We aimed to elucidate the genomic and transcriptomic variation in 1054 unsolved STGD and STGD-like probands. Methods Sequencing of the complete 128-kb ABCA4 gene was performed using single-molecule molecular inversion probes (smMIPs), based on a semiautomated and cost-effective method. Structural variants (SVs) were identified using relative read coverage analyses and putative splice defects were studied using in vitro assays. Results In 448 biallelic probands 14 known and 13 novel deep-intronic variants were found, resulting in pseudoexon (PE) insertions or exon elongations in 105 alleles. Intriguingly, intron 13 variants c.1938-621G>A and c.1938-514G>A resulted in dual PE insertions consisting of the same upstream, but different downstream PEs. The intron 44 variant c.6148-84A>T resulted in two PE insertions and flanking exon deletions. Eleven distinct large deletions were found, two of which contained small inverted segments. Uniparental isodisomy of chromosome 1 was identified in one proband. Conclusion Deep sequencing of ABCA4 and midigene-based splice assays allowed the identification of SVs and causal deep-intronic variants in 25% of biallelic STGD1 cases, which represents a model study that can be applied to other inherited diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available